Takeda Pharmaceutical dividend and valuation
¥5,639.00Change from previous close: −0.07%Absolute change: −¥4.00
Valuation
Takeda Pharmaceutical paid ¥202.00 per share in dividends over the last 12 months (yield 3.6%). Last ex-dividend date: September 29, 2026. The average price target of 16 analysts is ¥6,622.06.
Data as of October 4, 2026
Valuation multiples
- Market cap
- ¥9.01T
- Enterprise value
- ¥13.99T
- Forward P/E
- 40.2
- PEG
- 0.41
- Price/book
- 1.18
- Price/sales
- 1.95
- EV/EBITDA
- 11.2
- EV/revenue
- 3.03
Profitability and growth
- Gross margin
- 64.5%
- Operating margin
- 16.4%
- Net margin
- -3.5%
- ROE
- -2.3%
- ROA
- 2.7%
- ROIC
- 5.1%
- Revenue growth (year over year)
- 10.2%
- Earnings growth (year over year)
- -9.8%
Financial health
- Total cash
- ¥460.98B
- Total debt
- ¥5.54T
- Debt/equity
- 0.73
- Current ratio
- 1.14
- Quick ratio
- 0.51
- Altman Z-Score
- 1.09
- Piotroski F-Score
- 4.00
Dividends
- Annual dividend per share
- ¥202.00
- Dividend yield
- 3.6%
- Payout ratio
- 167.2%
- Ex-dividend date
- September 29, 2026
Analysts and estimates
- Average price target
- ¥6,622.06
- Median price target
- ¥6,750.00
- High price target
- ¥7,600.00
- Low price target
- ¥5,800.00
- Analysts with a price target
- 16
- Consensus
- Buy
- Forward EPS
- ¥140.39
- EPS estimate, current year
- ¥126.30
Shares and trading
- Beta
- 0.10
- Average volume
- 4.11M
- Shares outstanding
- 1.6B
- Float
- 1.58B
- Institutional ownership
- 50.1%
- Insider ownership
- 0.0%